Similar articles

• Effects of prenatal glucocorticoid exposure on cardiac calreticulin and calsequestrin protein expression during early development and in adulthood.

  Langdown ML, Holness MJ, Sugden MC. Langdown ML, et al. Biochem J. 2003 Apr 1;371(Pt 1):61-9. doi: 10.1042/BJ20021771. Biochem J. 2003. PMID: 12519072 Free PMC article.
• Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation.

  Finken MJ, Keijzer-Veen MG, Dekker FW, Frölich M, Walther FJ, Romijn JA, van der Heijden BJ, Wit JM; Dutch POPS-19 Collaborative Study Group. Finken MJ, et al. Arch Dis Child Fetal Neonatal Ed. 2008 Nov;93(6):F442-7. doi: 10.1136/adc.2007.128470. Epub 2008 May 1. Arch Dis Child Fetal Neonatal Ed. 2008. PMID: 18450806
• Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.

  Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M. Ventolini G, et al. Am J Perinatol. 2008 Feb;25(2):79-83. doi: 10.1055/s-2007-1022470. Epub 2008 Jan 10. Am J Perinatol. 2008. PMID: 18188800
• [Delayed birth of the second child in multiple gestation].

  Weemhoff M, van Meir CA, Walther FJ, Twaalfhoven FC, van Roosmalen J. Weemhoff M, et al. Ned Tijdschr Geneeskd. 2001 Jul 21;145(29):1377-80. Ned Tijdschr Geneeskd. 2001. PMID: 11494684 Review. Dutch.
• Drugs in the perinatal period: implications for the preterm infant.

  Rudd CC, Brazy JE. Rudd CC, et al. Compr Ther. 1988 Dec;14(12):30-7. Compr Ther. 1988. PMID: 3067970 Review. No abstract available.